Seeking Alpha

TheDean's  Instablog

TheDean
Send Message
The Dean is the world's foremost blogger and educator about small cap stocks at http://www.CollegeStock.com. He also serves as a management and marketing consultant to small businesses.
  • $ABIO Announces Patent for Bucindol (Gencaro) 0 comments
    Mar 27, 2010 8:36 PM | about stocks: ABIO
    ARCA Biopharma, Inc. (NASDAQ: ABIO) is a biopharmaceutical company focused on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States.

    $ABIO is up on massive volume of more than 20 million shares, which, for this stock, is more than 850 times its 3 month average volume.

    What’s so special about $ABIO? This morning, $ABIO announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent on methods of treating heart failure patients with Bucindolol based on genetic testing.

    The student body knows that The Dean’s big on patents, especially when it comes to pharma companies. The parent, U.S. #7,678,824, “Methods for Treatment with Bucindol Based on Genetic Testing,” provides protection for $ABIO’s novel approach to treating patients with heart failure.

    The press release detailing this development suggests that approximately 5.7 million Americans have heart failure and nearly 670,000 new patients are diagnosed each year.

    Additionally, heart failure is believed to be the underlying cause for approximately 12 million to15 million annual visits to physicians, 6.5 million annual hospital days and more than $37 billion in healthcare costs in the United States alone.

    So far today, $ABIO has traded as high as $9.11 per share, or 243%, since yesterday’s close of$2.65.

    Since The Dean cannot officially recommend, he wants his students to think about his favorite expression, “The Trend is Your Friend!



    Disclosure: none
    Stocks: ABIO
Back To TheDean's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.